Etiome Analysis: $50M Raised
What is Etiome?
Preemptive medicines to disrupt disease progression
Location
Cambridge, United States
Employees
11-50
Founded
2021
Product Features & Capabilities
- Biostaged Medicines for disease prevention
- Stage-specific therapies for targeted populations
Use Cases
Develop therapies to slow disease progression; Target specific patient populations with tailored treatments; Prevent irreversible damage from diseases; Address biological shifts during disease stages; Deploy medicines at optimal times for patient health
See something that needs updating? Suggest edits to this profile.